FDA.reportPublic FDA data

Alvaiz 18 MG Oral Tablet

RxCUI
2675193
RxNorm name
Alvaiz 18 MG Oral Tablet
Display name
Alvaiz 18 MG Oral Tablet
Full name
Alvaiz 18 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALVAIZELTROMBOPAGTeva Pharmaceuticals, Inc.ed51e463-7a03-4858-bbd2-882ce4753d5a2026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2675193

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ed51e463-7a03-4858-bbd2-882ce4753d5aAlvaiz 18 MG Oral Tablet [PSN] · eltrombopag 18 MG Oral Tablet [Alvaiz] [SBD] · Alvaiz 18 MG (as eltrombopag choline 22.2 MG) Oral Tablet [SY] · Alvaiz 18 MG Oral Tablet [SY]47These highlights do not include all the information needed to use ALVAIZ safely and effectively. See full prescribing information for ALVAIZ . ALVAIZ ® (eltrombopag tablets), for oral use Initial U.S. Approval: 200820260130